profit from every $100 of sales.
$0$100
Select Medical
We have no price for Select Medical since 30 June 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$16.51-0.12% today
+25.2% since Oct 13, 25
1-year low $12.741-year high $16.66
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $13.99 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Select Medical sold, what it kept, and what it did with the cash.
Sales went from $4.61 billion in 2022 to $5.45 billion in 2025, with $146 million of profit last year.
SalesProfit
Select Medical handed back more cash to shareholders than it generated last year.
Buybacks $100M$31M
Free cash flow 2025$117M
Bought back its own shares$100M
Paid as dividends$31M
Cash vs. debt$27M vs. $2.9B
Select Medical vs. similar companies
Select Medical grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Select Medical | 14.0× · Cheap | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
Compare Select Medical with Encompass Health
AI analysis
An AI analyst reads Select Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,609 | 4,826 | 5,187 | 5,453 | |
| 401 | 572 | 634 | 629 | |
| 145 | 267 | 268 | 336 | |
| 379 | 503 | 507 | 531 | |
| 159 | 243 | 214 | 146 | |
| 1.23 | 1.91 | 1.66 | 1.16 | |
| 8.7% | 11.8% | 12.2% | 11.5% | |
| 3.1% | 5.5% | 5.2% | 6.2% | |
| 3.4% | 5.0% | 4.1% | 2.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 7,665 | 7,690 | 5,608 | 5,852 |
| Cash | 98 | 53 | 60 | 27 |
| Total debt | 5,157 | 4,525 | 2,704 | 2,869 |
| Total liabilities | 6,275 | 6,116 | 3,611 | 3,816 |
| 1,122 | 1,288 | 1,681 | 1,706 | |
| 123 | 123 | 125 | 123 | |
| 2.2% | 4.0% | 5.5% | 6.7% | |
| 14.2% | 18.9% | 12.7% | 8.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 285 | 582 | 518 | 346 | |
| 190 | 229 | 222 | 229 | |
| 94 | 353 | 296 | 117 | |
| Dividends paid | 65 | 64 | 65 | 31 |
| 196 | 13 | 38 | 100 | |
| 38 | 44 | 101 | 17 |
Valuation
- 14.0×
- –
- –
- –
- 0.4×
- 17.5×
- 9.2×
- 5.7%
- 7.1%
- 1.5%
Profitability
- 11.5%
- 6.2%
- 2.7%
- –
- –
- –
- –
- –
- –
- –
Growth
- +5.8%
- −1.9%
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 38%of 894
Top 19%of 632
Bottom 33%of 908
Top 19%of 991
What analysts expect
- Average price target
- $19.00
- Range
- $19.00 – $19.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 0.36 | 0.43 | −16.3% |
| Feb 19, 2026 | 0.16 | 0.23 | −30.4% |
| Oct 30, 2025 | 0.23 | 0.18 | +27.8% |
| Jul 31, 2025 | 0.32 | 0.28 | +14.3% |
| May 1, 2025 | 0.44 | 0.45 | −2.2% |
| Feb 20, 2025 | 0.18 | 0.29 | −37.9% |
| Oct 31, 2024 | 0.43 | 0.43 | +0.0% |
| Aug 1, 2024 | 0.60 | 0.61 | −1.6% |
1.5%of the share price, paid each year
On $1,000 invested$15a year at today's yield, before tax
–per share
Raised–not every year
Paid per share, each year
$0.05 in 2015 → $0.25 in 2025
How safe it looks
21.5% of its profit
Room to growStretchedMore than it earns: 26.8%
News
What State Street Tech Select SPDR (XLK) Sold: Apple Leads on Nov. 9Yahoo Finance · Nov 11, 2026Technology Select Sector SPDR (XLK) Adds Oracle, Trims Apple on Nov. 4Yahoo Finance · Nov 6, 2026JPMorgan Global Select Equity ETF (JGLO) Adds Microsoft and NXP on Oct. 29Yahoo Finance · Nov 2, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
38No pass
Benjamin Graham
42No pass
Philip Fisher
13No pass
Peter Lynch
13No pass
Joel Greenblatt
25No pass
Charlie Munger
28No pass
Terry Smith
30No pass
Questions about Select Medical
Is Select Medical a good stock to buy?
A business with weak numbers, and the price looks low. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Select Medical AI analysis
What does Select Medical do?
Select Medical Holdings Corporation (SEM) is a U.S.-based healthcare organization that manages a diverse portfolio of specialized medical facilities. It is in Medical - Care Facilities.
Does Select Medical pay a dividend?
Yes. At today's price the dividend is 1.5% a year, about 21% of its yearly profit. In 2025 it paid out $31.4 million in dividends.
Who are Select Medical's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with Select Medical's.
Prices: daily closes to Jun 30, 2026. Fundamentals: company reports via invest-like data.